Edition:
United States

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

4.94USD
4:00pm EDT
Change (% chg)

$0.15 (+3.13%)
Prev Close
$4.79
Open
$4.83
Day's High
$5.00
Day's Low
$4.79
Volume
15,034
Avg. Vol
48,062
52-wk High
$5.72
52-wk Low
$0.51

Chart for

About

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $150.47
Shares Outstanding(Mil.): 31.41
Dividend: --
Yield (%): --

Financials

  CERC.OQ Industry Sector
P/E (TTM): 8.19 240.92 34.18
EPS (TTM): 0.58 -- --
ROI: 47.27 -5.87 13.17
ROE: 100.57 -7.71 15.15

BRIEF-Cerecor Posts Q1 Loss Of $0.12 Per Share

* CERECOR - PROJECTS 2018 ADJUSTED EBITDA TO BE ABOUT BREAK-EVEN Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 11 2018

BRIEF-Cerecor Q4 Loss Per Share $0.11

* REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017

Apr 02 2018

BRIEF-Cerecor Inc Appoints Peter Greenleaf CEO

* CERECOR APPOINTS PETER GREENLEAF AS CHIEF EXECUTIVE OFFICER

Mar 28 2018

BRIEF-Cerecor To Acquire Avadel Pharmaceuticals' Pediatric Assets

* CERECOR TO ACQUIRE AVADEL PHARMACEUTICALS' PEDIATRIC ASSETS

Feb 12 2018

Earnings vs. Estimates